A little girl in Wellington blew out candles on her third birthday surrounded by princess decorations, balloons, and laughter—exactly the kind of moment any parent dreams of. For Courtney and Jordan Carr, though, the celebration carried a quiet weight. Their daughter Madison, bright-eyed and full of mischief, is living with a rare terminal genetic disorder that doctors say will likely limit her life to just a few years.
Her story has since sparked a conversation in New Zealand about something most families rarely think about: hidden genetic risks.
A Joyful Childhood Shadowed by a Rare Diagnosis
Madison Carr is, by every account, a joyful child. She adores dolls, twinkling Christmas lights, and playing with friends. Her mum describes her as “happy, laughy and so cheeky.”
But behind that cheerful personality lies a devastating diagnosis: metachromatic leukodystrophy (MLD) — a rare inherited disorder that progressively damages the brain and nervous system.
Doctors told Madison’s parents that most children diagnosed with the condition live only until around the age of five.
The diagnosis came as a complete shock to the family. Neither Courtney nor Jordan had any idea they carried the genetic mutation responsible for the disease.
“It’s recessive, so we both carry the gene,” Courtney explained. “We come from big families with lots of siblings and relatives and there’s never been any sign of it before.”
Understanding Metachromatic Leukodystrophy
MLD is an extremely rare genetic condition caused by the body’s inability to break down certain fatty substances called sulfatides. These substances then build up in the brain and nerves, gradually destroying the protective myelin sheath that allows nerve cells to communicate.
Over time, the disease affects movement, speech, cognition, and eventually vital bodily functions.
| Key Facts About MLD | Details |
|---|---|
| Type of disorder | Rare inherited metabolic disease |
| Cause | Mutation in the ARSA gene |
| Inheritance | Autosomal recessive |
| Risk when both parents are carriers | 25% chance child will have the disease |
| Main impact | Progressive damage to brain and nervous system |
| Typical outcome | Life expectancy often around early childhood |
Because it is autosomal recessive, both parents must carry the same faulty gene for a child to develop the condition. When that happens, each pregnancy has:
- 25% chance the child will have the disease
- 50% chance the child will be a carrier
- 25% chance the child will inherit no mutation
This pattern is outlined by the U.S. National Library of Medicine’s genetics database (https://medlineplus.gov/genetics/condition/metachromatic-leukodystrophy/).
Early Signs That Something Was Wrong
Like most children, Madison initially seemed to be developing normally.
Her parents began noticing small changes as she approached her second birthday. She struggled to progress from taking a few steps to walking independently, something that had previously seemed within reach.
Eventually she began losing some abilities she had already gained.
After months of appointments and testing, doctors initially believed she had cerebral palsy. But as her condition continued to decline, specialists ordered more detailed testing, including genetic screening.
That’s when the real diagnosis emerged.
“We got the diagnosis and a referral to palliative care on the same day,” Courtney recalled.
For any parent, those words land like a shockwave.
Life Today: Good Days, Difficult Days
Madison still has moments of joy and independence. She can crawl and pull herself up to stand, though balance can be difficult.
Just a few months ago she could walk short distances across the room, sometimes using a walker. Now, that ability has disappeared.
Her parents say they haven’t seen her walk in four or five months.
Still, they try to focus on the happiness she brings.
“Some days are really good,” Courtney said. “She’s smiling and laughing and being her cheeky self.”
The Genetic Testing Question
Madison’s diagnosis has made Courtney think deeply about something she had never considered before pregnancy: genetic carrier testing.
“If we had known before we got pregnant, we would have chosen IVF to have our family,” she said.
Through IVF with genetic screening, embryos can be tested for specific inherited conditions before implantation. This process, called preimplantation genetic testing, allows parents to avoid passing on certain genetic disorders.
The U.K.’s National Health Service has recently expanded access to genetic testing programs aimed at identifying inherited risks before pregnancy (https://www.nhs.uk/conditions/genetic-and-genomic-testing/).
In New Zealand, however, testing availability is more limited.
| Type of Genetic Testing in New Zealand | Availability |
|---|---|
| Newborn screening | Publicly funded for some conditions |
| Testing with family history | Available through public health services |
| Carrier screening before pregnancy | Mostly private providers |
According to Health New Zealand’s Genetic Health Service (https://www.tewhatuora.govt.nz/our-health-system/preventative-health/genetic-health-service-nz/), most rare conditions like MLD are not detected until symptoms begin.
Health officials say expanded carrier screening is still an emerging issue currently being evaluated by the National Screening Advisory Committee.
A Family Focused on Making Memories
For the Carr family, the future is uncertain—but the present is precious.
Rather than focusing only on the diagnosis, they are building a bucket list of experiences for Madison.
Plans include:
- Feeding giraffes at the zoo
- Celebrating Easter with extended family
- Hosting a “mid-winter Christmas” filled with lights and decorations she loves
A Givealittle fundraising page has also been created to help support Madison’s care and make those experiences possible.
For her parents, every moment matters.
Her little brother Joey, who has been identified as a carrier of the gene but does not have the disease, remains her constant companion.
Courtney says one of the hardest realities is knowing he may eventually lose his best friend.
“Knowing there is no good outcome here, and that Joey is going to lose his best friend, is horrific,” she said.
Why Their Story Matters
The Carr family hopes sharing Madison’s journey will encourage more conversations about genetic testing and hidden hereditary conditions.
Many families assume that if no disease has appeared in their family tree, the risk must be negligible. But recessive conditions can remain hidden for generations before appearing unexpectedly.
“If I could go back,” Courtney said, “I would test for everything.”
For now, the family’s focus is simple: fill Madison’s life with love, laughter, and unforgettable memories.
Because while the years may be few, every day with her is priceless.
FAQs
What is metachromatic leukodystrophy (MLD)?
MLD is a rare genetic disorder that damages the brain and nervous system by preventing the body from breaking down certain fatty substances.
How is MLD inherited?
It is inherited in an autosomal recessive pattern, meaning both parents must carry the gene mutation for a child to develop the disease.
Can MLD be cured?
Currently, there is no widely available cure, though some experimental therapies and gene treatments are being studied.
What are early symptoms of MLD in children?
Early signs often include difficulty walking, loss of previously learned skills, muscle weakness, and developmental regression.